Emerging therapeutic targets in ovarian cancer

Emerging therapeutic targets in ovarian cancer [electronic resource] / Stan Kaye [and others], editors.

Show other versions (1)

This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.

Saved in:
Bibliographic Details
Online Access: Full Text (via Springer)
Other Authors: Kaye, Stanley B.
Format: Electronic eBook
Language:English
Published: New York : Springer Science+Business Media, LLC, ©2011.
Subjects:
Ovaries > Cancer > Treatment.
Table of Contents:
  • Preface; Contents; Contributors; 1 Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs; 2 Discovery of Novel Targets; 3 Novel Anti-angiogenic Therapies in Ovarian Cancer; 4 Targeting the AKT Pathway in Ovarian Cancer; 5 Inhibition of the Src Oncogene: Therapeutic PotentialINTbreak; in Ovarian Carcinoma; 6 Tumour-Specific Synthetic Lethality: Targeting BRCA Dysfunction in Ovarian Cancer; 7 Targeting Inflammatory Pathways in Epithelial Ovarian Cancer.
  • Systemic Therapy for Ovarian Cancer, Current Treatment, Recent Advances, and Unmet Needs / Susana Banerjee, Michael A. Bookman, and Martin Gore
  • Discovery of Novel Targets / John Farley and Michael J. Birrer
  • Novel Anti-angiogenic Therapies in Ovarian Cancer / Jurjees Hasan and Gordon Jayson
  • Targeting the AKT Pathway in Ovarian Cancer / Euan A. Stronach [and others]
  • Inhibition of the Src Oncogene : Therapeutic Potential in Ovarian Carcinoma / Liz Y. Han and Anil K. Sood
  • Tumour-Specific Synthetic Lethality : Targeting BRCA Dysfunction in Ovarian Cancer / Timothy A. Yap [and others]
  • Targeting Inflammatory Pathways in Epithelial Ovarian Cancer / Jermaine Coward and Frances Balkwill
  • Epithelial-to-Mesenchymal Transition and Cellular Membrane Receptors in Ovarian Cancer : Moving Forward in the Era of Molecularly Targeted Therapy / Lainie P. Martin, Julia J. Perkins, and Russell J. Schilder
  • Epigenetic Therapies / Robert Brown, Nadine Chapman-Rothe, and Ros Glasspool
  • Ovarian Cancer Immunology and Immunotherapy / Sadaf Ghaem-Maghami and Martin Gore
  • Ovarian Cancer Progenitor/Stem Cells: Therapeutic Potential / Susan K. Murphy and Andrew Berchuck
  • Potential for α-Folate Receptor-Targeted Treatment for Ovarian Cancer / Chau H.M. Ng and Ann L. Jackman
  • New Insights into Tubulin Binders / Carles Escriu and James D. Brenton.

Similar Items